Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Mayumi Nakagawa

Concepts (217)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Papillomavirus Infections
15
2024
168
4.580
Why?
Human papillomavirus 16
11
2021
44
3.620
Why?
Uterine Cervical Neoplasms
10
2024
276
3.380
Why?
Papillomavirus Vaccines
7
2021
67
3.300
Why?
Oncogene Proteins, Viral
11
2011
52
2.460
Why?
Papillomaviridae
7
2019
103
2.330
Why?
Repressor Proteins
9
2011
148
2.110
Why?
Epitopes, T-Lymphocyte
7
2018
25
1.910
Why?
Cancer Vaccines
3
2021
80
1.610
Why?
T-Lymphocytes
6
2021
325
1.430
Why?
Candida
4
2018
59
1.340
Why?
CD8-Positive T-Lymphocytes
6
2018
125
1.310
Why?
Cervix Uteri
3
2021
42
0.880
Why?
Uterine Cervical Dysplasia
2
2015
49
0.840
Why?
Immunity, Cellular
4
2013
63
0.740
Why?
Lymphocytes, Tumor-Infiltrating
1
2021
76
0.720
Why?
Epitopes
2
2015
59
0.710
Why?
Langerhans Cells
3
2018
11
0.700
Why?
Neoplasms
2
2021
1255
0.680
Why?
Viral Load
2
2019
76
0.660
Why?
Health Education
1
2021
153
0.650
Why?
Cell Cycle Checkpoints
1
2019
29
0.640
Why?
HLA Antigens
4
2006
52
0.620
Why?
Colorectal Neoplasms
1
2021
260
0.580
Why?
CD4-Positive T-Lymphocytes
3
2018
158
0.570
Why?
Humans
40
2024
50516
0.570
Why?
Adult
20
2021
13584
0.560
Why?
Female
28
2024
27086
0.550
Why?
Health Knowledge, Attitudes, Practice
1
2021
491
0.540
Why?
Plasma Exchange
2
2014
25
0.510
Why?
Cross Protection
1
2015
5
0.490
Why?
T-Lymphocytes, Regulatory
2
2016
82
0.490
Why?
Colposcopy
1
2015
17
0.480
Why?
Interleukin-12
2
2018
29
0.470
Why?
Adjuvants, Immunologic
2
2018
51
0.470
Why?
Immunity, Innate
1
2015
105
0.460
Why?
Interferon-gamma
2
2012
177
0.440
Why?
Health
1
2013
23
0.440
Why?
Lectins, C-Type
1
2013
30
0.440
Why?
Papillomavirus E7 Proteins
8
2018
31
0.440
Why?
Young Adult
9
2021
4107
0.430
Why?
Patient Selection
1
2015
259
0.420
Why?
Middle Aged
14
2021
12613
0.420
Why?
Afibrinogenemia
1
2012
5
0.410
Why?
Enzyme-Linked Immunospot Assay
1
2012
3
0.400
Why?
T-Lymphocytes, Cytotoxic
4
2009
63
0.390
Why?
Breast Neoplasms
1
2021
1200
0.390
Why?
Cell Proliferation
5
2021
985
0.370
Why?
Vaginal Smears
3
2021
28
0.370
Why?
Early Detection of Cancer
3
2021
163
0.360
Why?
Warts
1
2010
13
0.360
Why?
Plateletpheresis
1
2010
7
0.360
Why?
Antigens, Fungal
1
2010
19
0.360
Why?
Blood Preservation
1
2010
26
0.350
Why?
Dermatitis
1
2010
35
0.350
Why?
Blood Proteins
1
2010
84
0.340
Why?
Anaphylaxis
1
2010
69
0.340
Why?
Cells, Cultured
5
2021
1571
0.320
Why?
Antigens, Viral
2
2009
42
0.310
Why?
Immunotherapy
1
2010
235
0.310
Why?
Telemedicine
1
2015
469
0.300
Why?
Human papillomavirus 18
1
2008
9
0.300
Why?
Blood Platelets
1
2010
251
0.290
Why?
Host-Pathogen Interactions
2
2021
135
0.290
Why?
Dendritic Cells
1
2008
135
0.280
Why?
Vaccinia virus
1
2007
6
0.280
Why?
Immunoenzyme Techniques
1
2007
137
0.270
Why?
Immunophenotyping
1
2007
105
0.270
Why?
Cell Line, Tumor
5
2021
1398
0.240
Why?
Isoantibodies
1
2004
29
0.230
Why?
Neoplasm Grading
2
2021
122
0.230
Why?
Lead
1
2004
33
0.230
Why?
Aged
9
2021
9743
0.230
Why?
Infant, Very Low Birth Weight
1
2004
48
0.230
Why?
Neutropenia
1
2004
116
0.220
Why?
Oropharyngeal Neoplasms
1
2024
19
0.220
Why?
DNA, Viral
3
2011
136
0.220
Why?
Anus Neoplasms
1
2024
24
0.220
Why?
Coinfection
1
2024
41
0.210
Why?
Blood Transfusion
1
2004
129
0.210
Why?
Penile Neoplasms
1
2024
44
0.210
Why?
Adolescent
5
2021
6446
0.210
Why?
High-Throughput Nucleotide Sequencing
2
2021
170
0.210
Why?
Antibody Formation
1
2002
50
0.200
Why?
Capsid Proteins
1
2002
24
0.200
Why?
Clone Cells
3
2007
70
0.190
Why?
Genes, T-Cell Receptor
1
2021
5
0.190
Why?
Treatment Outcome
3
2021
5285
0.190
Why?
Clinical Trials, Phase I as Topic
1
2021
25
0.190
Why?
Cytokines
2
2016
606
0.190
Why?
Pilot Projects
2
2021
699
0.190
Why?
Mass Screening
2
2021
344
0.180
Why?
Remission Induction
1
2021
208
0.180
Why?
Cystadenocarcinoma, Serous
1
2021
71
0.180
Why?
Lymphocyte Activation
1
2021
164
0.180
Why?
Videotape Recording
1
2021
26
0.180
Why?
Left-Right Determination Factors
1
2020
1
0.180
Why?
Nodal Protein
1
2020
3
0.180
Why?
Amino Acid Sequence
3
2008
574
0.180
Why?
Mammography
1
2021
101
0.180
Why?
Focus Groups
1
2021
194
0.170
Why?
Enzyme-Linked Immunosorbent Assay
3
2010
234
0.170
Why?
Male
10
2024
25913
0.160
Why?
Metagenome
1
2019
40
0.160
Why?
Glioblastoma
1
2020
94
0.160
Why?
Dose-Response Relationship, Drug
2
2016
1372
0.160
Why?
Feasibility Studies
1
2021
391
0.160
Why?
Parenteral Nutrition
1
2019
28
0.160
Why?
Up-Regulation
1
2020
446
0.160
Why?
Health Behavior
1
2021
253
0.150
Why?
Transplantation Conditioning
1
2019
87
0.150
Why?
DNA
1
2021
535
0.150
Why?
Time Factors
2
2021
2935
0.150
Why?
Bacteria
1
2019
218
0.150
Why?
Leukocytes, Mononuclear
2
2016
118
0.140
Why?
Multiple Myeloma
1
2012
2998
0.140
Why?
HLA-B Antigens
2
2008
7
0.140
Why?
Cell Line
2
2012
988
0.140
Why?
Age Factors
1
2021
1110
0.140
Why?
Ovarian Neoplasms
1
2021
450
0.140
Why?
Brain Neoplasms
1
2020
291
0.140
Why?
Histocompatibility Antigens Class II
2
2008
37
0.130
Why?
Vaccines, Subunit
1
2016
15
0.130
Why?
Head and Neck Neoplasms
1
2019
288
0.130
Why?
Body Mass Index
1
2019
677
0.120
Why?
Molecular Sequence Data
2
2008
778
0.120
Why?
Adaptive Immunity
1
2015
32
0.120
Why?
Chromatography, Liquid
1
2016
231
0.120
Why?
Leukocyte Count
2
2004
69
0.120
Why?
Peptides
2
2006
221
0.120
Why?
Tandem Mass Spectrometry
1
2016
238
0.120
Why?
Factor VIII
1
2014
23
0.120
Why?
ADAM Proteins
1
2014
20
0.110
Why?
Purpura, Thrombotic Thrombocytopenic
1
2014
16
0.110
Why?
Proteome
1
2016
169
0.110
Why?
Mannose-Binding Lectins
1
2013
7
0.110
Why?
Antigens, CD1
1
2013
8
0.110
Why?
Receptors, Pattern Recognition
1
2013
4
0.110
Why?
Indicators and Reagents
1
2013
37
0.110
Why?
Intracellular Space
1
2013
25
0.110
Why?
Hematopoietic Stem Cell Transplantation
1
2019
577
0.110
Why?
Skin Tests
1
2013
55
0.110
Why?
Vaccination
1
2016
280
0.110
Why?
Cadherins
1
2013
63
0.110
Why?
Proteomics
1
2016
314
0.110
Why?
Communication
1
2015
250
0.100
Why?
Research Design
1
2015
353
0.100
Why?
Rural Health Services
1
2015
169
0.100
Why?
Antigens, CD
1
2013
222
0.100
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2013
572
0.100
Why?
Socioeconomic Factors
1
2015
591
0.100
Why?
Longitudinal Studies
2
2005
735
0.090
Why?
Injections, Intralesional
1
2010
31
0.090
Why?
Isotonic Solutions
1
2010
17
0.090
Why?
Platelet Transfusion
1
2010
29
0.090
Why?
P-Selectin
1
2010
32
0.090
Why?
Sodium Chloride
1
2010
55
0.090
Why?
Platelet Aggregation
1
2010
70
0.090
Why?
Platelet Activation
1
2010
45
0.090
Why?
Hypersensitivity
1
2010
75
0.080
Why?
Retrospective Studies
3
2019
6264
0.080
Why?
Polymerase Chain Reaction
1
2010
449
0.080
Why?
HLA-A Antigens
1
2008
10
0.080
Why?
Antigen Presentation
1
2008
25
0.080
Why?
Immunologic Memory
1
2008
29
0.070
Why?
Histocompatibility Antigens Class I
1
2008
46
0.070
Why?
Signal Transduction
2
2020
1624
0.070
Why?
DNA, Recombinant
1
2007
15
0.070
Why?
Animals
2
2019
13124
0.070
Why?
Genes, MHC Class I
1
2006
10
0.070
Why?
Arkansas
1
2013
1984
0.070
Why?
Binding, Competitive
1
2006
94
0.070
Why?
Neoplasm Staging
1
2008
746
0.060
Why?
Calgranulin B
1
2005
4
0.060
Why?
Calgranulin A
1
2005
5
0.060
Why?
Immunomagnetic Separation
1
2004
7
0.060
Why?
Epitope Mapping
1
2004
6
0.060
Why?
Risk Factors
1
2013
3723
0.060
Why?
Phosphorylation
2
2020
525
0.050
Why?
Sensitivity and Specificity
1
2005
861
0.050
Why?
Tumor Virus Infections
1
2002
47
0.050
Why?
Antibodies, Viral
1
2002
93
0.050
Why?
Lactobacillus
1
2021
6
0.050
Why?
SOX Transcription Factors
1
2021
4
0.050
Why?
Immunoglobulin G
1
2002
190
0.050
Why?
Neuroendocrine Cells
1
2021
10
0.050
Why?
Biological Specimen Banks
1
2021
21
0.050
Why?
Cytodiagnosis
1
2021
41
0.050
Why?
Cytoplasm
1
2021
89
0.050
Why?
Cobalt
1
2020
16
0.040
Why?
Recurrence
1
2002
659
0.040
Why?
Cohort Studies
1
2004
1452
0.040
Why?
Vulnerable Populations
1
2020
47
0.040
Why?
Cell Hypoxia
1
2020
82
0.040
Why?
Neoplastic Stem Cells
1
2021
98
0.040
Why?
Epithelial-Mesenchymal Transition
1
2020
51
0.040
Why?
Cell Movement
1
2021
247
0.040
Why?
Community Health Workers
1
2020
51
0.040
Why?
Multivariate Analysis
1
2021
583
0.040
Why?
Parenteral Nutrition, Total
1
2019
31
0.040
Why?
Sequence Analysis, DNA
1
2019
226
0.040
Why?
Cell Survival
1
2020
589
0.040
Why?
Cell Differentiation
1
2021
640
0.040
Why?
Phenotype
1
2021
739
0.040
Why?
Linear Models
1
2019
279
0.040
Why?
Models, Biological
1
2021
716
0.040
Why?
Immunity, Humoral
1
2018
22
0.040
Why?
Infant, Newborn
1
2004
2749
0.030
Why?
Gene Expression Regulation, Neoplastic
1
2020
833
0.030
Why?
Prognosis
1
2021
1977
0.030
Why?
Autoantibodies
1
2014
117
0.030
Why?
Immunosuppressive Agents
1
2014
225
0.030
Why?
Mice, Inbred C57BL
1
2018
1808
0.030
Why?
Combined Modality Therapy
1
2014
641
0.020
Why?
Mice
1
2018
5687
0.020
Why?
Casein Kinase II
1
2005
10
0.010
Why?
Cell Division
1
2005
291
0.010
Why?
Nakagawa's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description